Today's technological innovation enables smartphone users to diagnose serious diseases such as diabetes or lung cancer quickly and effectively by simply breathing into a small gadget, a nanofiber breathing sensor, mounted on the phones. Il-Doo Kim, Associate Professor of Materials Science and Engineering Department at the Korea Advanced Institute of Science and Technology...
Professor Il-Doo Kim of Materials Science & Engineering, KAIST, developed an exhaled breath sensor that is composed of highly porous tin dioxide (SnO2) nanofibers with a unique nanostructure functionalized by catalytic platinum (Pt) particles. This unique structure reacts to acetone gas, which is known as a biomarker of diabetes, for the fast diagnosis of the disease within 10 seconds.
Diagnostic technology covers a broad range of equipment, tests, and medical fields, and recent advancements in technique and materials means that innovations are widespread and growing rapidly. Though economic conditions are preventing huge advancements in diagnostic imaging—if hospitals can’t afford the new technology, there is no point in designing it—the medical imaging community is focusing on refinement, rather than redesign.
Wake Forest Baptist Medical Center doctors have found that using stress cardiac magnetic resonance (CMR) imaging in an Emergency Department observation unit to care for patients with acute chest pain is a win-win - for the patient and the institution.
Just a few years ago, integrated positron emission tomography and magnetic resonance (PET/MR) imaging was found only in research institutes, but little by little the technology has expanded into clinical practice. This is especially true for cardiac indications, for which the highly sensitive soft tissue contrast of MR and the functional and metabolic imaging of PET are particularly valuable.
Coronary artery disease (CAD) is one of the world’s most prevalent and silent killers. Positron emission tomography (PET), which images miniscule abnormalities in cellular metabolism, can tip off clinicians about cardiac disasters waiting to happen—including sudden death from a heart attack—better than standard angiography, researchers revealed at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.
The Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting marks the unveiling of the successful application of a new preclinical hybrid molecular imaging system—single photon emission tomography and magnetic resonance—which has exceptional molecular imaging capabilities in terms of potential preclinical and clinical applications, technological advancement at a lower cost, and reduction of patient exposure to radiation.
New research analyzing breast cancer mortality data spanning almost 40 years concludes that breast cancer screening does not yet show an effect on mortality statistics. The research, published in the Journal of the Royal Society of Medicine, analyzed mortality trends before and after the introduction of the National Health Service Breast Screening Programme in 1988.
Chemists at the University of Pittsburgh have demonstrated a sensor technology that could significantly simplify the diagnosis and monitoring of diabetes through breath analysis alone. Their findings were published in the latest issue of the Journal of the American Chemical Society (JACS).
New technology under development at The Ohio State University is paving the way for low-cost electronic devices that work in direct contact with living tissue inside the body. The first planned use of the technology is a sensor that will detect the very early stages of organ transplant rejection.
Ingestible medical devices offer a convenient, non-invasive method of delivering therapeutics, enabling diagnostic procedures, or performing imaging tasks. However, ensuring that the sensitive electronics within the device are protected is a challenge. This article will highlight a coating technology that is being used to guarantee such protection is provided.
Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene® MycoplasmaJune 10, 2013 10:30 am | by Business Wire | News | Comments
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it has received FDA clearance for a new molecular diagnostic test for Mycoplasma pneumonia ( M. pneumoniae ), its fourth assay on the illumi gene platform. This innovative test that aids in identifying an important respiratory pathogen is a strong addition to the illumi gene platform.
Blood vessels within a sensory area of the mammalian brain loop and connect in unexpected ways, a new map has revealed. The study, published June 9 in the early online edition of Nature Neuroscience, describes vascular architecture within a well-known region of the cerebral cortex and explores what that structure means for functional imaging of the brain and the onset of a kind of dementia.
MRI scans of children who have had chemotherapy can detect early changes in their hearts finds research in biomed Central's open access journal Journal of Cardiovascular Magnetic Resonance. Chemotherapy with anthracyclines, such as Doxorubicin, is one of the most effective treatments against many types of cancer, including leukaemia and Hodgkin's lymphoma, breast, lung, and ovarian cancer.
A new study has found that women can be screened for colorectal cancer at least five to 10 years later than men when undergoing an initial "virtual colonoscopy." Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may help establish guidelines for the use of this screening technique, which is less invasive than a traditional colonoscopy.
Three out of 20 flexible gastrointestinal (GI) endoscopes used for screening were found to harbor unacceptable levels of "bio dirt" – cells and matter from a patient's body that could pose potential infection risk -- according to a study of endoscopes used at five hospitals across the U.S.
The average 5-year survival for colorectal cancer is less than 10% if metastasis occurs, but can reach 90% if detected early. A new non-invasive test has been developed that measures methylation of the SDC2 gene in tissues and blood sera. This test detected 87% of all stages of colorectal cancer cases (sensitivity) without significant difference between early and advanced stages.
New research has found that routine screening using a non-invasive test that analyzes fetal DNA in a pregnant woman's blood can accurately detect Down's syndrome and other genetic fetal abnormalities in the first trimester. Published early online in Ultrasound in Obstetrics & Gynecology, the results suggest that the test is superior to currently available screening strategies and could reshape standards in prenatal testing.
Today, two scientists from Cold Spring Harbor Laboratory (CSHL) publish a mathematical method of simplifying and interpreting genome data bearing evidence of mutations, such as those that characterize specific cancers. Not only is the technique highly accurate; it has immediate utility in efforts to parse tumor cells, in order to determine a patient's prognosis and the best approach to treatment.
MRI may be an effective way to diagnose mental illnesses such as bipolar disorder, according to experts from the Icahn School of Medicine at Mount Sinai. In a landmark study using advanced techniques, the researchers were able to correctly distinguish bipolar patients from healthy individuals based on their brain scans alone. The data are published in the journal Psychological Medicine.
NJIT Assistant Professor Mei Liu, PhD, a computer scientist, has recently shown in a new study that electronic medical records can validate previously reported adverse drug reactions and report new ones. "EMRs have created an unprecedented resource for observational studies since they contain not only detailed patient information, but also large amounts of longitudinal clinical data," she said.
IBM and Brightlight today announced that Seattle Children’s Hospital is using IBM Big Data technology to improve treatment of its young patients. With over 350,000 patient visits annually and thousands of data points associated with each patient, Seattle Children’s Hospital can run queries on patient data in seconds, rather than minutes, to provide quicker, more effective care and diagnosis.
The portable medical devices industry is a fast growing world. With the advent of various smart technology and wireless capabilities, this medical field has become one of the most intriguing with the promise of great potential for future healthcare.
Human factors engineering, as applied to the design of medical devices, has never been as important as it is today, especially since the release of the U.S. FDA’s draft guidance document Applying Human Factors and Usability Engineering to Optimize Medical Device Design. With the rise of mobile health apps, human factors engineering principles will become even more vital to the success of this industry and to the safety of the patients.
Much of Atkins and Patel’s research centers on ion channels – proteins that act as pores within cell membranes and enable electrical currents to pass in and out of cells. They recently developed new technology to transfer DNA into cells. The development is an inexpensive and non-toxic method to help DNA cross the cell membrane so that cells can be modified.